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Abstract 
A survey (via SurveyMonkey) was sent to lung cancer patients, their caregivers or significant others asking about their 
experience in making difficult treatment decisions. Of the 198 respondents, 118 (69%) indicated that they had faced a 
difficult decision with respect to their lung cancer treatment. Of those, 73% indicated that they would have desired that 
the decision be made with their physician using a shared decision-making process, and 58% perceived that such a 
process had occurred. In addition, only 23% of respondents indicated that they had had the right amount of information 
when making the decision. Fortunately, only 9% of respondents expressed regret regarding the decision they ultimately 
made. A Patient Decision Aid (PDA) was made available to the respondents to view, and opinions were sought 
regarding the usefulness of this type of format for presenting information. This format was perceived as helpful, unsure 
if helpful, or not helpful by 62%, 36%, and 2% of respondents, respectively. In summary, the majority of lung cancer 
patients want to make difficult decisions using a shared decision-making process. The patient perception is that this is 
not occurring often enough. Even in this fairly well-educated group of respondents, many report that they are not sure 
that they have all the information necessary to make that difficult decision. Physicians may need help developing their 
communication and shared decision-making skills. Introducing PDAs into the oncology clinic may represent a way to 
present complex information and improve the patient experience. 
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Introduction 
 
Oncologists often ask lung cancer patients to make 
important decisions regarding their treatment, often within 
the setting of a single consultation.  Patients are presented 
with treatment options that are sometimes associated with 
a significant degree of uncertainty as to their risks and 
benefits. The Institute of Medicine expressed the opinion 
that shared decision-making was necessary to produce the 
best clinical outcomes possible.1 How oncologists present 
information can be instrumental in what treatment 
decision is made, the subsequent physician-patient 
relationship, and the degree of regret experienced by the 
patient should things not go as well as expected.  
 
When one treatment option is not clearly superior to 
another, Patient Decision Aids (PDAs) can help present 
risks and benefits in a simple, visual format.2 A survey of 
lung cancer patients or their significant others/caregivers 
collected information regarding their decision-making 
experiences, and their perceived usefulness of PDAs.)  
 
Methods 
 
A survey (via SurveyMonkey) was sent to lung cancer 
patients, caregivers or significant others who had signed 
up for email communication from the Bonnie Addario 
Lung Cancer Foundation (ALCF), Global Resource for 
Advancing Cancer Education (GRACE), or the University 
of Colorado.  Non-patient respondents were asked to 
answer the survey, including the demographic information, 
as they would have anticipated the patient would have 
answered.   In addition to the multiple choice format of 
the SurveyMonkey questionnaire, all questions provided 
the option to give freestyle comments.  The survey process 
and questions were approved by the Institutional Review 
Board of the University of Colorado.  
In order to seek opinions regarding the usefulness of 
PDAs, a representative part of a PDA was shown (Figure 
1).  The figure provided was typical of how a PDA 
presents the risks and benefits in a simple way, using 
numerical and visual formats, combined with a very short 
narrative.2 There was also a link to a full PDA for those 
interested in seeing it.   
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The survey was sent out in January 2016 and by September 
2016, 198 completed surveys had been received.    
 
Results 
 
The demographics of the survey respondents are 
summarized in Table 1. Given the distribution of the 
survey through USA-based advocacy associations, it is not 
surprising that the majority (83%) of respondents were 
from the USA.  The median age of respondents was 51-60 
years old but all ages were represented. It was a relatively 
well-educated group with 83% of respondents having 
attended at least some college.  Sixty-nine percent of the 
respondents were married.  Respondents were more likely 
to be white females. There were no Native American, 
Alaskan Native, Native Hawaiian or Pacific islanders.  
 
Respondents were asked if they had faced a difficult 
decision regarding their treatment.   Sixty-nine percent of 
the 198 respondents indicated that they had faced a 
difficult decision. Women were more likely than men to 
indicate that they had had a difficult decision to make 
(83% vs 65%, p<0.05).   
 
The stage of lung cancer was Stage I or II (primary tumor 
in lung without spread to mediastinal lymph or distant 
organs, Stage III (primary tumor in lung with spread to 
mediastinal lymph nodes without spread to distant organs), 
Stage IV (metastatic to distant organs), or not known, in 
15%, 14%, 56% and 15% of respondents, respectively. 
Figure 1. Survey question regarding the usefulness of a PDA 
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The treatment situations associated with the difficult 
decision are shown in Table 2.  Under the “Other” 
category respondents commented frequently on the 
dilemma about joining a clinical trial, seeking a second 
opinion, or changing treatment course due to toxicities.   
 
When asked why the decision was difficult (again, more 
than one answer was allowed), the most common answer 
was that they felt they did not have enough information 
(44%) or that they had heard conflicting information or 
recommendations from their doctors (33%).  Other cited 
reasons were that they felt rushed to make the decision 
(30%), heard conflicting information from non-medical 
sources such as friends or internet (20%), disagreement 
with significant other/support team (9%).  Additional free 
style comments alluded to practical issues (e.g., work, 
expense, insurance, financial) with travelling for treatment 
or for a second opinion, depression or feelings of futility 
and helplessness, and difficulty dealing with the unknown. 
   
Respondents used a variety of sources to help make the 
decision although their physicians and the internet were 
the most commonly cited sources (81% and 70%, 
respectively).  Table 3 summarizes these responses.  
Respondents who indicated “Other” had varied comments 
such as “relying on their gut feelings,” or indicated that 
they used many of these sources and chose this response 
as a default.   
 
The amount of information available was categorized as 
insufficient, just right, too much or difficult to know in 
14%, 23%, 2%, 50%. Eleven percent preferred to answer 
the question with explanations.  Most of these comments 
expressed confusion and uncertainty about the 
information needed to make the “right” decision.   Men 
were more likely to indicate that they had “just the right 
amount of information,” 39% vs 14%, p< 0.05. 
   
Respondents were asked how “they would have liked to 
make the decision” in terms of collaboration with their 
physicians and family.  The most common answer was that 
they wanted their doctor(s) to make the decision jointly 
with them (73%), with half indicating that they wished to 
also have their family also involved in making the decision.  
However, only 58% of respondents felt that their decision 
Table 1. Demographics of 198 survey respondents 
 
Demographic variable N (%) 
Respondent 
     Patient 
     Caregiver/support person 
 
127 (64%) 
   71 (36%) 
Country 
     United States 
     Canada 
     Other/No answer 
 
163 (83%) 
 15  (8%) 
  20  (9%) 
Age (yrs) 
     < 30  
     31-40 
     41-50 
     51-60 
     61-70 
     71-80 
     > 81 
     No answer 
 
4  (2%) 
15 (8%) 
30 (15%) 
59 (30%) 
54 (27%) 
20 (10%) 
4   (2%) 
12 (6%) 
Highest level of school completed 
    Elementary or middle school 
    High school or equivalent 
    Some college but no degree 
    Associate or bachelor degree 
    Graduate degree 
    No answer 
 
2 (1%) 
15 (8%) 
26 (13%) 
73 (37%) 
68 (34%) 
14 (7%) 
Relationship status 
    Married 
    Widowed 
    Divorced 
    Single, never married 
    Other/No answer 
 
137 (69%) 
8      (4%) 
18    (9%) 
13    (8%) 
22   (10%) 
Gender 
    Male 
    Female 
    No answer 
 
42 (21%) 
128 (65%) 
28 (14%) 
Ethnic heritage 
    White 
    Black 
    Asian 
    Multi-cultural 
   No answer 
 
150  (76%) 
1    (.5%) 
12   (6%) 
4    (2%) 
31  (10.5%) 
 
Table 2. Treatment or situation associated with the difficult decision  
 
Treatment modality or situation % of respondents 
Tests that were done or not done 34% 
Surgery 29% 
Radiation therapy 29% 
Chemotherapy (including targeted therapy) 56% 
End of life care 12% 
Other* 24% 
*See text 
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had been a shared decision with their doctors, with or 
without their family’s input.  Ten percent of respondents 
indicated that the decision was primarily made by their 
doctors. Unfortunately, 26% of respondents indicated that 
they had made the decision by themselves.   There was no 
gender difference identified in the opinion regarding the 
PDA, or regarding the wish for, or perception of, the 
degree to which the decision was made jointly with their 
doctors. 
 
Respondents were asked if they regretted the decision that 
they had made.  Answers were given on a 5-point scale: 1 
(strongly agree), 2 (agree), 3 (neither agree or disagree), 4 
(disagree) or 5 (strongly disagree).  Interestingly only 9% 
of respondents expressed regret (answered 1 or 2) 
regarding the decision that they had made.  There was no 
difference in this expression of regret between men and 
woman.  The following freestyle comments were offered 
by respondents who expressed regret over the decision. 
 
• Regret that even the oncologist glossed over my 
questions regarding (drug) sequencing 
• Not enough tissue obtained for more comprehensive 
testing 
• I still wish my MD was more informative.  I am 
medical, intelligent and aware enough to handle the 
tough realities.  Just talk to me.  I’m not in denial or 
living in an illusion. 
• Not given some kind of follow-up PET scan post-
surgery.  Wonder if preventative chemo might have 
eradicated the early activity. 
• I wish surgeon was more upfront about 
complications.  I got every complication imaginable.  
Surgeon made it sound like piece of cake. 
• Whether to participate in a clinical trial or not. 
 
Respondents were then shown a representative part of a 
PDA (Figure 1) and asked if this type of decision aid 
would have been helpful.  Of the 91 respondents to this 
question, 62% felt that a PDA would be helpful, and only 
2% felt it would not be helpful.  The remainder weren’t 
sure or offered suggestions regarding modifying the PDA.  
 
At the conclusion of the survey, respondents were given 
the opportunity to make additional comments.  Of the 40 
additional comments, many indicated that they had faced 
multiple difficult decisions throughout their illness.  They 
highlighted the complexity of making personal treatment 
decisions based on the statistics available.  Many were 
appreciative of having the opportunity to answer the 
survey, and hoped that further research into shared 
decision-making would be forthcoming  
 
Discussion 
 
The importance of physicians and patients working 
together to make decisions was highlighted in the Institute 
of Medicine (IOM) report Crossing the Quality Chasm.1 
This IOM report referred to patient-centered care as “care 
that is respectful of and responsive to individual patient 
preferences, needs, and values” and that ensures “that 
patient values guide all clinical decisions.”   The IOM 
expressed the opinion that shared decision-making was 
necessary to produce the best clinical outcomes possible.   
 
Patients vary in their medical knowledge, but even a 
patient who has done substantial research prior to the 
consultation might have difficulty in applying that 
information to his or her own situation.  In addition, 
patients vary in the extent to which they want to be 
involved in the decision-making process.3 This was 
apparent in our results in which approximately 75% of 
patients wanted to be involved in making the difficult 
decision. 
 
Patient education materials are not meant to replace the 
patient-physician consultation but to improve the decision 
process.  Often patients arrive at consultations or follow-
up appointments not knowing the results of tests 
indicating a need for a change in management, or there 
may be an actual or perceived need to make a quick 
Table 3. Sources of information utilized by respondents (multiple sources allowed) 
 
Source of information Respondent number (%) 
Doctors 90 (81%) 
Internet 78 (70%) 
Books, pamphlets or other written material 35 (31%) 
Lung cancer patient advocacy groups or foundations 51 (47%) 
Friends or family 53 (47%) 
Other people with lung cancer (more informally than 
patient advocacy group) 
28 (25%) 
Nurses 24 (21%) 
Other 30 (27%) 
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decision during that patient-physician interaction.  Patients 
often look to their health providers to point them to 
appropriate education sources to support shared decision-
making. However, even a patient who has done substantial 
research prior to the consultation might have difficulty in 
applying that information to his or her own situation.   In 
addition, patients vary in the extent to which they want to 
be involved in the decision-making process.3  
 
Another way in which oncologists can promote patient-
centered care is by providing a written document 
summarizing the treatment options discussed, and their 
associated risks and benefits. Providing patients with a 
visit summary has been designated as a quality indicator by 
Medicare, part of the Meaningful Use criteria, by which 
medical facilities can recoup some of their investment in 
installing an electronic medical record (EMR).4 Other 
techniques that have been shown to be effective include 
the provision of pertinent published literature, tape 
recordings of the interview, copies of the office notes, and 
telephone calls before or after the visit.5 Older lung cancer 
patients may benefit from written materials that are 
presented in a particular format.  The Centers for Disease 
Control and Prevention (CDC) has suggested guidelines 
for oral and written questions with older adults or 
caregivers 
(http://www.cdc.gov/healthliteracy/developmaterials/aud
iences/olderadults. Accessed July 23, 2017).   
 
Interestingly, patients are likely to be more satisfied with 
the decision-making process if the physician 
communicates the uncertainty associated with their 
treatment recommendation.6 Clinicians need to relinquish 
their role as the single, paternalistic authority and train to 
become more effective coaches or partners. They have to 
be comfortable asking, “What matters to you?” or “What 
is the matter?”7 
 
Another validated way of communicating the uncertainty 
surrounding treatment options is the use of patient 
decision aids (PDAs).8 PDAs can be used when there is 
more than one reasonable option, when no option has a 
clear advantage in terms of health outcomes, and when 
each option has benefits and harms that patients may value 
differently. PDAs may be in the form of written 
information, videos, or web-based tools that make the 
decision explicit, summarize the options available, and 
help people to understand these options as well as their 
possible benefits and harms.9 PDAs may contain real 
patient antidotes in which one or the other decision was 
made, with both good and bad outcomes. One expert 
review concluded that effective PDAs present the risks 
and benefits in numerical and visual formats, combined 
with some narrative, and must take into account the ability 
of the patient to understand the material2. 
  
The effectiveness of PDAs in cancer varies from tool to 
tool, and there is controversy regarding the depth of 
information that should be presented to the patient.10-12 
However, a Cochrane review regarding shared decision-
making concluded that PDAs lead to significant changes in 
the following variables.8 
 
▪ Increased patient knowledge 
▪ More accurate patient assessments of the 
treatment risk 
▪ Lower decisional conflict related to feeling 
uninformed 
▪ Reduced passivity in decision-making 
▪ Reduced number of undecided patients 
▪ Improved effect on patient-practitioner 
communication  
 
The Cochrane review also concluded that, on average, the 
use of a PDA only increased the length of consultation by 
approximately 3 minutes.   
 
Of the 600 plus validated PDAs, less than 60 of these are 
designed for cancer treatment decisions, and only 10 deal 
with lung cancer diagnosis or treatment 
(www.ohri.ca/decisionaid. Accessed July 20, 2017). These 
can be accessed by patients and oncologists on the 
internet. Clearly there is room for the development of 
other lung cancer PDAs. 
   
Unfortunately, the conclusions that can be drawn from 
this survey are limited by the relatively homogeneous 
population of respondents, primarily white Caucasian, 
well-educated patients with access to the internet.  A 
future comparison of these results with other patient 
populations would be extremely interesting.   
 
In summary, lung cancer patients frequently face difficult 
treatment decisions, and most, but not all, want to 
participate in a shared decision-making process with their 
doctor.  However, the patient perception is that this is not 
occurring as often as it could or should.  Even in this fairly 
well-educated group of respondents with access to many 
educational resources, many report that they are not sure 
that they had all the information necessary to make a 
shared decision.   Physicians may need encouragement and 
education to develop their shared decision-making skills. 
This could take the form of more open discussion to 
explore the patient’s values and priorities, for example 
asking the patient “what really matters to you?”.  
Introducing more PDAs into the oncology clinic may 
represent another way to present complex information and 
enhance the shared decision-making process.   
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